Correlation Between EnVVeno Medical and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both EnVVeno Medical and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnVVeno Medical and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between enVVeno Medical Corp and Lipocine, you can compare the effects of market volatilities on EnVVeno Medical and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnVVeno Medical with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnVVeno Medical and Lipocine.

Diversification Opportunities for EnVVeno Medical and Lipocine

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between EnVVeno and Lipocine is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding enVVeno Medical Corp and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and EnVVeno Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enVVeno Medical Corp are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of EnVVeno Medical i.e., EnVVeno Medical and Lipocine go up and down completely randomly.

Pair Corralation between EnVVeno Medical and Lipocine

Given the investment horizon of 90 days enVVeno Medical Corp is expected to generate 0.57 times more return on investment than Lipocine. However, enVVeno Medical Corp is 1.74 times less risky than Lipocine. It trades about -0.01 of its potential returns per unit of risk. Lipocine is currently generating about -0.05 per unit of risk. If you would invest  346.00  in enVVeno Medical Corp on August 28, 2024 and sell it today you would lose (6.00) from holding enVVeno Medical Corp or give up 1.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

enVVeno Medical Corp  vs.  Lipocine

 Performance 
       Timeline  
enVVeno Medical Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days enVVeno Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Lipocine 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

EnVVeno Medical and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with EnVVeno Medical and Lipocine

The main advantage of trading using opposite EnVVeno Medical and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnVVeno Medical position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind enVVeno Medical Corp and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing